BOSTON, MA — November 15, 2022 — Alcanza Clinical Research, a mission-focused investigator site network, announces the appointment of Jeremy Rigby as Chief Growth Officer. A twenty-year veteran of the biopharmaceutical industry, Jeremy will identify and lead opportunities to expand organizational capabilities that provide the essential infrastructure for Alcanza’s growth strategy. He will also provide oversight for integration activities across the company’s rapidly expanding site network.
Jeremy’s vast experience spans clinical operations, corporate development, and leadership roles at a pharmaceutical company, contract research organization, and investigator site network. Most recently, he served as president of a site network that began as a single clinical trial site and grew into a regional network of 12 sites across five states under his leadership.
“I am delighted to have an executive leader of Jeremy’s stature join Alcanza as Chief Growth Officer,” said Carlos Orantes, CEO of Alcanza Clinical Research. “This new role is part of our plan to expand clinical research beyond its traditional domain. Jeremy brings a deep understanding of the changing research environment and our customers’ need for holistic solutions across a range of therapeutic areas. His unique combination of talents will accelerate our ability to enroll diverse patient populations and deliver on the promise of inclusive research.”
“I am so excited to be a part of Alcanza,” said Jeremy. “I am impressed with the mix of site specialties, and the breadth of experience across the network. We are entering an era where clinical research is undergoing transformational change, and I’m looking forward to helping Alcanza lead this change with a focus on new approaches to clinical trial access and health equity through inclusive research.”
Jeremy is a graduate of Duke University’s Fuqua School of Business and Brigham Young University.